TotalMarketCap

Vistagen Therapeutics

VTGNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.367 M

$0.17 -9.93%

Close of 6 Nov 2026

As of 6 Nov 2026, Vistagen Therapeutics (VTGN) has a market capitalization of $7.37M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$69.7M

Loss-making

Shares outstanding

41,032,453

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #429Theriva BiologicsTOVX$7.43M
  2. #430Alzamend NeuroALZN$7.38M
  3. #431Vistagen TherapeuticsVTGN$7.37M
  4. #432SoligenixSNGX$7.25M
  5. #433InMed PharmaceuticalsINM$7.14M

What if Vistagen Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$636,296.53

Per share 3,833,112× higher

Bitcoin $1.53T

$34,428.90

Per share 207,403× higher

Apple $5.02T

$113,026.86

Per share 680,885× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Vistagen Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.